Calliditas Therapeutics AB (publ)
CALT · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$466,185 | -$421,943 | -$524,456 | -$379,720 |
| Dep. & Amort. | $16,594 | $12,913 | $34,433 | $2,823 |
| Deferred Tax | $0 | $0 | -$65,672 | $7,625 |
| Stock-Based Comp. | $52,591 | $35,791 | $21,960 | $6,012 |
| Change in WC | -$79,741 | $88,420 | $5,470 | $54,083 |
| Other Non-Cash | $207,606 | -$26,535 | $66,677 | -$4 |
| Operating Cash Flow | -$434,655 | -$311,354 | -$461,588 | -$309,181 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12,787 | -$2,512 | -$22,654 | $0 |
| Net Acquisitions | $0 | $0 | -$47,021 | -$172,602 |
| Inv. Purchases | -$1,560 | -$2,633 | -$1,686 | -$5 |
| Inv. Sales/Matur. | $602 | $0 | $71,361 | $0 |
| Other Inv. Act. | $1 | $1 | -$24,340 | -$172,607 |
| Investing Cash Flow | -$13,745 | -$5,144 | -$24,340 | -$172,607 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $226,276 | $482,130 | $193,949 | -$3,972 |
| Stock Issued | $0 | $236 | $324,000 | $891,388 |
| Stock Repurch. | $0 | -$236 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$26,626 | $93,860 | -$82,787 | -$118,858 |
| Financing Cash Flow | $199,650 | $575,990 | $435,162 | $768,558 |
| Forex Effect | -$26,611 | $34,094 | $9,969 | -$44,006 |
| Net Chg. in Cash | -$275,361 | $293,587 | -$40,797 | $242,764 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,249,094 | $955,507 | $996,304 | $753,540 |
| End Cash | $973,733 | $1,249,094 | $955,507 | $996,304 |
| Free Cash Flow | -$447,442 | -$313,866 | -$484,242 | -$309,181 |